Amryt Pharma plc provided earnings guidance for the full year 2022. for the year, the company expects revenue of $260 million - $270 million which represents growth of 17%-21% over 2021.
1st Jan change | Capi. | |
---|---|---|
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+57.16% | 25.43B | |
-18.49% | 11.49B | |
-44.02% | 11.3B | |
-15.61% | 11.1B | |
+4.12% | 8.75B | |
-8.42% | 7.99B |